Antibody–Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome–Disruptive Peptide

[Image: see text] Antibody–drug conjugates are an important class of cancer therapeutics. These agents generally bind a specific cell surface receptor, undergo receptor-mediated endocytosis, and enter the endosomal–lysosomal system, where the environment in these organelles facilitates the release o...

Descripción completa

Detalles Bibliográficos
Autores principales: Knewtson, Kelsey E., Perera, Chamani, Hymel, David, Gao, Zhe, Lee, Molly M., Peterson, Blake R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690568/
https://www.ncbi.nlm.nih.gov/pubmed/31460422
http://dx.doi.org/10.1021/acsomega.9b01585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690568/
https://www.ncbi.nlm.nih.gov/pubmed/31460422
http://dx.doi.org/10.1021/acsomega.9b01585

Ejemplares similares